Summit Global Investments - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.

Quarter-by-quarter ownership
Summit Global Investments ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q1 2021$740,000
+13.1%
7,964
+9.1%
0.05%
-27.7%
Q4 2020$654,000
-12.4%
7,300
+0.9%
0.06%
-15.6%
Q3 2020$747,000
-37.0%
7,234
-51.8%
0.08%
-43.8%
Q2 2020$1,186,000
+34.9%
14,995
-1.3%
0.14%
+7.0%
Q1 2020$879,000
-10.9%
15,195
-16.9%
0.13%
+19.6%
Q4 2019$987,000
+34.7%
18,295
+30.5%
0.11%
+25.9%
Q3 2019$733,000
-13.0%
14,020
+9.5%
0.08%
-24.8%
Q3 2018$843,000
+30.5%
12,8000.0%0.11%
+16.5%
Q2 2018$646,000
+4.9%
12,800
+9.4%
0.10%
-1.0%
Q1 2018$616,00011,7000.10%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Values First Advisors, Inc. 152,699$519,1780.34%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 299,187$1,017,0000.22%
Hilltop Holdings Inc. 235,019$799,0640.09%
AIMZ Investment Advisors, LLC 51,372$174,6650.08%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 868,605$2,953,2570.07%
PALISADE CAPITAL MANAGEMENT, LP 509,325$1,731,7050.05%
SHERBROOKE PARK ADVISERS LLC 41,417$140,8180.04%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 2,428,490$8,256,8660.03%
Y-Intercept (Hong Kong) Ltd 75,362$256,2310.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,246,020$4,236,4680.02%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders